Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cuisset T et al. – The present findings suggest the preferential use of pantoprazole compared with omeprazole in patients receiving clopidogrel to avoid any potential negative interaction with CYP2C19.

Related Articles

A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09    Relevance Score: 45%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 45%

Gender and Responses to Aspirin and Clopidogrel: Insights Using Short Thrombelastography
Cardiovascular Drug Reviews, 11/17/09    Relevance Score: 43%

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09    Relevance Score: 43%

Effects of clopidogrel on aspirin specific pathways of platelet inhibition
Platelets, 10/02/09    Relevance Score: 43%

Today in Vascular Medicine...keeping you current

Platelet Inhibition with Cangrelor in Patients Undergoing PCI
New England Journal of Medicine, 12/10/09

Cardiovascular risk factor assessment after pre-eclampsia in primary care
BMC Family Practice, 12/10/09

Peripheral arterial disease in women
Maturitas, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address